StockData
Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd (TKPHF) stock

TKPHFOTCPharmaceutical PreparationsAlso trades as TAK
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30
$39.00+0.36 (+0.93%)

Close on Oct 19, 2026Market cap $134.41BP/E –Yield –

Takeda Pharmaceutical total assets

Total assets on the balance sheet at the end of each period.

Takeda Pharmaceutical's total assets was ¥15.51T at Mar 31, 2026. For fiscal 2026 it was ¥15.51T, up 8.9% from the year before. The highest annual figure on record is ¥15.51T in fiscal 2026.

Annual total assets

PeriodPeriod endValueChange
FY2026Mar 31, 2026¥15.51T+8.9%
FY2025Mar 31, 2025¥14.25T-5.7%
FY2024Mar 31, 2024¥15.11T+8.2%
FY2023Mar 31, 2023¥13.96T+5.9%
FY2022Mar 31, 2022¥13.18T+2.1%
FY2021Mar 31, 2021¥12.91T+0.7%
FY2020Mar 31, 2020¥12.82T-7.0%
FY2019Mar 31, 2019¥13.79T+235.9%
FY2018Mar 31, 2018¥4.11T–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2026Mar 31, 2026¥15.51T+17.7%
Q4 FY2025Mar 31, 2025¥14.25T+10.3%
Q4 FY2024Mar 31, 2024¥15.11T+17.8%
Q4 FY2023Mar 31, 2023¥13.96T+1.2%
Q4 FY2022Mar 31, 2022¥13.18T+220.9%
Q4 FY2021Mar 31, 2021¥12.91T–
Q4 FY2020Mar 31, 2020¥12.82T–
Q4 FY2019Mar 31, 2019¥13.79T–
Q4 FY2018Mar 31, 2018¥4.11T–

More Takeda Pharmaceutical figures